673333680	673333680	CD	B-NP	O
|	|	NNP	I-NP	O
JMH	JMH	NNP	I-NP	O
|	|	VBD	B-VP	O
05887992	05887992	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
275292	275292	CD	B-NP	O
|	|	CC	I-NP	O
6/16/2001	6/16/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Infected	Infected	JJ	I-NP	I-protein
R	R	NN	I-NP	I-protein
THR	THR	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/16/2001	6/16/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/19/2001	6/19/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
FOSSELMAN	FOSSELMAN	NN	I-NP	O
,	,	,	O	O
JONAS	JONAS	NNP	B-NP	O
G	G	NNP	I-NP	O
876-42-92-0	876-42-92-0	CD	I-NP	O
Dier	Dier	NNP	I-NP	O
Drive	Drive	NNP	I-NP	O
,	,	,	O	O
Villevo	Villevo	NNP	B-NP	O
Ttawi	Ttawi	NNP	I-NP	O
Tlloa	Tlloa	NNP	I-NP	O
Belle	Belle	NNP	I-NP	O
,	,	,	O	O
North	North	NNP	B-NP	O
Dakota	Dakota	NNP	I-NP	O
03596	03596	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ORT	ORT	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/29/01	1/29/01	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Eval	Eval	NNP	I-NP	O
by	by	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRINIUS	BRINIUS	NNP	B-NP	O
,	,	,	O	O
MIKEL	MIKEL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
650	650	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
headache	headache	NN	I-NP	O
VENTOLIN	VENTOLIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
PUFF	PUFF	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
sob/wheeze	sob/wheeze	VB	B-VP	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

CEFTRIAXONE	CEFTRIAXONE	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
IV	IV	CD	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PERCOCET	PERCOCET	NN	I-NP	O
1-2	1-2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
pain	pain	NN	I-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	TO	B-VP	O
WORK	WORK	NN	I-VP	O
:	:	:	O	O
after	after	IN	B-PP	O
eval	eval	NN	B-NP	O
by	by	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Ashurst	Ashurst	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Lobato	Lobato	NNP	I-NP	O
9/10/01	9/10/01	CD	I-NP	O
,	,	,	O	O
VH	VH	NNP	B-NP	O
pre-admit	pre-admit	JJ	B-ADJP	O
for	for	IN	B-PP	O
OR	OR	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
&	&	CC	I-NP	I-protein
D	D	NN	I-NP	I-protein
/	/	SYM	B-NP	O
removal	removal	NN	B-NP	O
hardware	hardware	NN	I-NP	O
.	.	.	O	O

9/10/01	9/10/01	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Shellfish	Shellfish	NN	B-NP	O
,	,	,	O	O
Morphine	Morphine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Infected	Infected	JJ	B-NP	O
R	R	NN	I-NP	O
THR	THR	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Infected	Infected	NNP	I-NP	O
R	R	NNP	I-NP	O
THR	THR	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hodgkins	hodgkin	NNS	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Hodgkins	Hodgkins	NNP	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Asthma	Asthma	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
R	R	NNP	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
septic	septic	JJ	I-NP	O
joint	joint	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
non	non	JJ	I-NP	O
Q	Q	NN	I-NP	O
wave	wave	NN	I-NP	O
MI	MI	NN	I-NP	O
;	;	:	O	O
Extensive	Extensive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
CT-guided	CT-guided	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
R	R	NN	I-NP	O
hip	hip	NN	I-NP	O
per	per	IN	B-PP	O
Radiology	Radiology	NN	B-NP	B-protein
10/26/01	10/26/01	CD	I-NP	I-protein
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
IV	IV	CD	I-NP	O
Abx	Abx	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Admitted	Admit	VBN	B-VP	O
from	from	IN	B-PP	O
office	office	NN	B-NP	O
10/26/01	10/26/01	CD	I-NP	O
for	for	IN	B-PP	O
infected	infected	JJ	B-NP	O
L	L	NN	I-NP	O
THR	THR	NN	I-NP	O
.	.	.	O	O

Aspiration	Aspiration	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
purulent	purulent	JJ	B-NP	O
material	material	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Ceftriaxone	Ceftriaxone	NN	B-NP	B-cell_line
per	per	IN	B-PP	I-cell_line
ID	ID	NN	B-NP	I-cell_line
consult	consult	NN	I-NP	I-cell_line
recs	rec	NNS	I-NP	I-cell_line
.	.	.	O	O

MIC	MIC	NN	B-NP	O
to	to	TO	B-PP	O
both	both	CC	O	O
PCN	PCN	NN	B-NP	B-protein
and	and	CC	O	O
Ceftriaxone	Ceftriaxone	NN	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

MRI	MRI	NN	B-NP	O
of	of	IN	B-PP	O
pelvis	pelvis	NN	B-NP	O
completed	complete	VBD	B-VP	O
6/27/01	6/27/01	CD	B-NP	O
as	as	IN	B-PP	O
pre-op	pre-op	JJ	B-NP	O
eval	eval	NN	I-NP	O
.	.	.	O	O

TU	TU	NNP	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
pre-op	pre-op	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
given	give	VBN	B-VP	O
extensive	extensive	JJ	B-NP	O
H/O	H/O	NN	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
unstentable	unstentable	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
per	per	IN	B-PP	O
last	last	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
3/5	3/5	CD	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
further	further	JJ	B-NP	O
d/w	d/w	NN	I-NP	O
PT	PT	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
adament	adament	NN	B-NP	O
about	about	IN	B-PP	O
being	be	VBG	B-VP	O
allowed	allow	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
D/C	D/C	NN	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
Abx	Abx	NNP	B-NP	O
for	for	IN	B-PP	O
July	July	NNP	B-NP	O
holiday	holiday	NNP	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
picture	picture	NN	I-NP	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
Dr	Dr	NNP	B-NP	O
Salkeld	Salkeld	NNP	I-NP	O
and	and	CC	O	O
ID	ID	NNP	B-NP	O
MD	MD	NNP	I-NP	O
agreed	agree	VBD	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
on	on	IN	B-PP	O
provision	provision	NN	B-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
return	return	VB	B-VP	O
immediately	immediately	RB	B-ADVP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
progressing	progress	VBG	B-VP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
R	R	NN	I-NP	B-protein
hip	hip	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
exam	exam	NN	I-NP	O
were	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
by	by	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
IV	IV	CD	B-NP	O
lon	lon	NN	I-NP	O
line	line	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
placed	place	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
D/C	D/C	NN	B-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
QD	QD	NN	B-NP	O
Ceftriaxone	Ceftriaxone	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
re-consulted	re-consulted	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
post-op	post-op	JJ	B-NP	O
1/2	1/2	CD	I-NP	O
for	for	IN	B-PP	O
re-eval	re-eval	NN	B-NP	O
of	of	IN	B-PP	O
abx	abx	NN	B-NP	O
choice	choice	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
presumed	presume	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
MIC	MIC	NN	I-NP	O
for	for	IN	B-PP	O
PCN/CTX	PCN/CTX	NN	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
available	available	JJ	B-ADJP	O
for	for	IN	B-PP	O
ascertation	ascertation	NN	B-NP	O
of	of	IN	B-PP	O
proper	proper	JJ	B-NP	O
long-term	long-term	JJ	I-NP	O
Abx	Abx	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Return	Return	VB	B-VP	O
immediately	immediately	RB	B-ADVP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
temps/shaking	temps/shake	VBG	B-NP	O
chills/pain	chills/pain	NN	I-NP	O
at	at	IN	B-PP	O
R	R	NN	B-NP	B-protein
hip	hip	NN	I-NP	I-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

D/C	D/C	NN	B-NP	O
home	home	NN	I-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
for	for	IN	B-PP	O
QD	QD	NN	B-NP	B-protein
CTX	CTX	NN	I-NP	I-protein
dosing	dosing	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

IV	IV	CD	B-NP	O
long	long	JJ	I-NP	O
line	line	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Re-admission	Re-admission	NN	B-NP	O
for	for	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
hardware	hardware	NN	I-NP	O
and	and	CC	I-NP	O
spacer	spacer	NN	I-NP	O
placement	placement	NN	I-NP	O
9/10/01	9/10/01	CD	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

IV	IV	CD	B-NP	O
Ceftriaxone	Ceftriaxone	NN	I-NP	O
per	per	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
2	2	CD	B-NP	I-protein
Gr	Gr	NN	I-NP	O
IV	IV	CD	B-NP	O
QD	QD	NN	I-NP	O
for	for	IN	B-PP	O
4/18/01	4/18/01	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BURKHARDT	BURKHARDT	NNP	B-NP	O
,	,	,	O	O
GIL	GIL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GS19	GS19	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/29/01	1/29/01	CD	I-NP	O
@	@	SYM	O	O
09	09	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

